Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtech Insight Team

Latest From Medtech Insight Team

Execs On The Move: September 2024

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

Leadership Executive Changes

Deals Shaping The Medtech And Diagnostics Industries, August 2024

An interactive look at medtech and diagnostics deals made during August 2024. Data courtesy of Biomedtracker.

Deals Financing

Deals Shaping The Medtech And Diagnostics Industries, July 2024

An interactive look at medtech and diagnostics deals made during July 2024. Data courtesy of Biomedtracker.

Deals Financing

Execs On The Move: August 2024

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

Leadership Executive Changes

Execs On The Move: July 2024

An interactive look at recent executive-level company changes and promotions in the medical device and diagnostics industries.

Leadership Executive Changes

Pink Sheet Podcast: US FDA Device Director Retires, PBM Execs On Capitol Hill, Voucher Program Renewal Push

Editors from the Pink Sheet and Medtech Insight discuss the retirement of Jeff Shuren, PBM executives again appear unscathed after another Capitol Hill appearance, and the growing push to ensure the FDA’s rare pediatric disease priority review voucher program is renewed.

Leadership Pricing Debate
See All
UsernamePublicRestriction

Register